Northern New Jersey Eye Institute on ZocDoc
Intraocular Lenses Service
Accommodative Lenses
Accommodative lenses work naturally with muscles in the eye to retain the eyes' ability to focus on nearby and distant objects and everything in between. With traditional IOLs, patients lose this ability after cataract surgery and often require corrective measures such as glasses or contact lenses.
Toric Lenses
Toric IOLs are specially designed for patients with astigmatism. Traditionally, surgical correction of astigmatism required making a series of small incisions (called LRIs) around the cornea to make it more spherical instead of football-shaped. Implanting toric IOLs often improves vision due to astigmatism without the need for these extra incisions, and also allows patients to enjoy a faster, more comfortable recovery.
Verisyse Phakic Intraocular Lens(IOL)
The Verisyse Phakic Intraocular Lens (IOL) can be implanted temporarily or permanently in the eye to improve vision in patients with moderate to severe nearsightedness. Many of these patients are not candidates for other corrective treatments such as LASIK, and are resigned to wearing thick glasses or contact lenses.
The cornea acts a lens in the front of the eye, bending light rays so that they focus on the retina. In nearsighted patients the cornea is elongated or steepened, so light rays focus in front of the retina and patients suffer from blurry vision. The Verisys IOL is implanted on the iris behind the cornea to correct the way light is focused and to improve vision. The cornea is left in place to retain the ability to focus between near and distant objects. The procedure is outpatient and takes 15-30 minutes under local anesthesia.
The Verisyse IOL has been used in over 150,000 procedures worldwide with precise and predictable results. The lenses are made with PMMA, the material used in cataract surgery for the last 50 years. Please schedule an appointment or consultation to find out if the Verisyse lens is right for you. Candidates should be over 21, have good eye health and stable vision, and should not be pregnant or nursing.
Intacs® Corneal Implants
A new FDA approved option for keratoconus filling the gap between contact lenses and a corneal transplant! Keratoconus is a progressive eye disease, which causes a thinning of the cornea, the clear front surface of the eye. As keratoconus progresses, the quality of one's vision deteriorates and contact lenses or glasses no longer become a satisfactory solution for most people. For many, an invasive corneal transplant was the only option – until now! Intacs prescription inserts are an exciting new option between contacts and a corneal transplant that may be the best possible option to stabilize the cornea and improve vision.
Intacs prescription inserts are indicated for use in the correction of nearsightedness and astigmatism for patients with Keratoconus, where contact lenses and glasses are no longer suitable.
Intacs prescription inserts are approved by the FDA for keratoconus under a Humanitarian Device Exemption (HDE).
TECNIS Multifocal IOL
If you are diagnosed with cataracts and are experiencing one or more of the following symptoms, you may be a candidate for the TECNIS® Multifocal Lens:
•Difficulty reading
•Difficulty seeing close objects
•Difficulty seeing to drive, especially at night
•Changing glasses prescriptions
•Needing bifocals
Ask your doctor if the TECNIS® Multifocal Lens is an option that is right for your lifestyle and eye health.
"Dr. Crane is one of less than 100 doctors in the United States to be able to bring this new technology to his patients."
"Dr. Crane is one of less than 100 doctors in the world who have been approved to participate in the iDose FDA trial"
iDose exchange
"Dr. Crane is one of less than 15 doctors in the United States to perform this procedure for his patients."
"Dr. Crane is one of less than 15 doctors in the world who were approved to participate in the iDose exchange FDA trial"
Infinite
"Dr. Crane is one of less than 15 doctors in the United States who were able to bring this new technology to his patients."
"Dr. Crane is one of less than 15 doctors who were approved to participate in the iStent Infinite FDA trial"
General
FDA issues warning for contaminated eye drops that can cause infection.
"Dr. Crane and Glaukos have a long history of working together on several medical device and pharmaceutical studies. He has been able to offer these technologies to his patients and the products from these studies have progressed to help treat hundreds of thousands of patients in need."
Employment Opportunity: Optometrist in Essex, Morris, and Union Counties
Dr. Crane Top Doctor 2019
Congratulations to Dr. Crane for being the 2nd surgeon in the United States to perform a new treatment for Glaucoma. We hope this treatment will bring further advances in the care of our glaucoma.
ASCRS Thanks Dr. Crane for Volunteer Work
Dr. Spier Named to OSN's Premier Surgeon 300
Dr. Spier: Weekend Comedian
Dionne Warwick on Dropless Surgery [VIDEO] (Surgery Performed by Dr. Spier)
Dr. Crane and Staff congratulate their patient Dr. William Scaife
Dr. Crane named to the ASCRS Council of 100
Dr Crane meets one of his favorite Sharks, Daymond John, at a book signing!